Search
for
Sort by
Research 361–390 of 629
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
- Off-label uses of retinoids in dermatology
- Zinc and Zinc Transporters in Dermatology
- Diphenylcyclopropenone-Induced Vitiligo in a Patient with Alopecia Universalis
- Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
- Update on Outcome Measures for Pediatric Systemic Lupus Erythematosus
- The Immunological Association between Alopecia Areata and Respiratory Diseases: A Systematic Review
- Medical Dermatology
- Apoptosis in Hair and Skin: A Review
- Treatment Advances for Acne Vulgaris: The Scientific Role of Cannabinoids
- Applications of Long-Pulse Alexandrite Laser in Cosmetic Dermatology: A Review
- Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Annual Convention in the Time of COVID
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- The Genus Astragalus Species as an Emerging Source of Bioactive Phytochemicals: A Review of Dermatological and Cosmetic Applications
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Insulin Resistance, Metabolic Syndrome, and Inflammatory Skin Disease
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Update From Dermatology Nurses’ Association Convention 2025
- Erlotinib-induced trichomegaly of eyelashes in lung cancer treatment: Epidermal growth factor receptor inhibitor side effect
- Cutaneous manifestations associated with substance use disorders
- Highlights from the Field of Pediatric Dermatology Research from the 2023 PeDRA Annual Conference
- Clinicopathologic Case 2: Multiple Intraoral White Lesions in a 55-year-old Female
- Comparative Characterization of Human Meibomian Glands, Free Sebaceous Glands, and Hair-Associated Sebaceous Glands Based on Biomarkers, Analysis of Secretion Composition, and Gland Morphology